This site is intended for healthcare professionals
GPnotebook TV
GPnotebook
Listen or subscribe on
LOG IN
Listen or subscribe on

Prescribing information for Jardiance (empagliflozin) for Great Britain and Northern Ireland.

This sponsored promotional content has been developed, organised, and funded by the Boehringer Ingelheim and Lilly Alliance and is intended for UK Healthcare professionals only. Promotional information regarding Boehringer Ingelheim and Lilly Alliance products will be discussed. GPnotebook has had no input into the content.

Long-term value of SGLT2 inhibitors: the evidence for SGLT2 inhibitors in providing long-term outcomes (Promotional, product-related content developed and funded by Boehringer Ingelheim and Lilly Alliance)

Sponsored
In this episode, Dr Kevin Fernando and Alia Gilani talk about the evidence for SGLT2 inhibitors in providing long-term outcomes for people living with type 2 diabetes.

Adverse events should be reported. Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone), or by e-mail: [email protected].

PC-GB-106689 | July 2022

Related episode

The content of this website is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. Any distribution or duplication of the information contained herein is strictly prohibited.

Copyright © 2023 Oxbridge Solutions Ltd. All rights reserved.

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.

This podcast episode is intended for healthcare professionals based in Great Britain and Northern Ireland

I am not a healthcare professional based in Great Britain or Northen Ireland
I confirm I am a healthcare professional based in Great Britain or Northern Ireland
GPnotebook_podcast_white-text

Would you like to receive updates about new podcast episodes by email? (You can unsubscribe at any time)